genetic epidemiology
-
What is genetic epidemiology?
Genetic epidemiology studies how genes and environmental factors impact human traits, health, and disease. It evolved from population genetics and epidemiology.
American geneticist Newton Morton defined it as the study of the causes, distribution, and control of disease among related individuals and the inherited causes of diseases in populations. This definition was broadened to include the role of the environment, as genetic factors often interact with environmental factors to affect disease.
Genetic epidemiology uses population-based approaches, case-control studies, and prevalence studies. It has contributed to medicine and public health, such as newborn screening to detect inherited disorders.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How does genetic epidemiology study the role of genes in health and disease?
Genetic epidemiology investigates the interplay of genes and environmental factors in health and disease within related individuals and populations. It uses population-based, case-control, and prevalence studies to gather data on clinical features and outcomes.
Approaches include linkage and association studies to find susceptibility genes, and family studies to compare familial versus population risks. By applying epidemiological methods like case-control and cohort studies, it examines genetic and environmental risk factors simultaneously. Genetic epidemiology has led to public health contributions such as newborn screening for inherited disorders.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is the difference between genetic and environmental factors in disease?
Genetic factors in disease relate to inherited mutations or variations in genes that can increase or decrease the risk of developing certain conditions. Environmental factors encompass a wide range of external influences, such as chemical, dietary, infectious, physical, and behavioral factors, that can impact health and disease susceptibility.
Most diseases arise from a combination of both genetic and environmental influences. For example, while some individuals may have a genetic predisposition to certain cancers, their lifestyle choices, such as smoking or diet, can further elevate their risk. Likewise, a genetic mutation may cause a disease; however, environmental modification can alter the gene expression.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How do scientists collect genetic information for epidemiological studies?
Scientists employ various approaches to collect genetic information for genetic epidemiology studies. Population-based approaches gather data on clinical features and outcomes, while case-control studies compare data from affected individuals and healthy controls.
Family studies assess disease risk in first-degree relatives, often comparing it to population risk. Genome-wide association studies require large sample sizes with genotype data derived from microarray analysis or next-generation sequencing. Ethical considerations, including participant consent, data ownership, and privacy, guide data collection.
6 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are some common methods used in genetic epidemiology research?
Genetic epidemiology employs diverse methods to study the interplay of genes and environmental factors in human health. Population-based approaches gather data on clinical features, outcomes, and socioeconomic factors in specific diseases. Twin studies help establish the role of genetic factors in multifactorial diseases, while association studies detect susceptibility genes.
Family studies compare disease risk in first-degree relatives to population risk, and genome-wide association studies (GWAS) scan the genome for genetic variations linked to diseases. These variations can assess disease risk and responses to therapies. Epidemiological methods like case-control and cohort studies examine genetic and environmental risk factors simultaneously.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How can findings from genetic epidemiology help prevent or treat diseases?
Genetic epidemiology enhances public health and medicine through identifying how genes and environmental factors impact diseases. Newborn screening, like that for sickle cell disease, illustrates this, as early penicillin administration reduced mortality in afflicted children.
Later research linked familial traits to psychiatric disorders and substance dependence, highlighting environmental factors. Consequently, minimizing exposure to these elements could lower the risk of such disorders.
Modern genetic epidemiology utilizes population-based, case-control, and prevalence studies, along with twin and family studies, to identify susceptibility genes and understand disease risk. This comprehensive approach helps translate genomic research into effective public health strategies.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
genetic epidemiology, the study of how genes and environmental factors influence human traits and human health and disease. Genetic epidemiology developed initially from population genetics, specifically human quantitative genetics, with conceptual and methodological contributions from epidemiology.
One of the early proponents of genetic epidemiology, American geneticist Newton Morton, defined the field as one that addresses the etiology, distribution, and control of disease in groups of related individuals and the inherited causes of diseases in populations. That definition later was broadened to include the role of the environment, owing to the realization that genetic factors frequently interact with environmental factors to influence disease in human populations. In 2003, scientists Muin J. Khoury, Julian Little, and Wylie Burke coined the term human genome epidemiology to encompass a system of study that uses the methods of epidemiology to understand the influence of genomic variation in both health and disease, thereby going beyond the influence of individual genes, which remained the primary focus of genetic epidemiology.
Modern genetic epidemiology includes all diseases, whether they are common and complex or supposedly simpler, such as the so-called monogenic (single-gene) disorders. Many advances in the epidemiology of genetic diseases have involved seemingly simple inherited disorders (e.g., cystic fibrosis, sickle cell disease). However, those advances have also indicated that even monogenic disorders can be highly complex, owing to epigenetic factors and interactions of disease genes with environmental factors. In addition to the broad focus on genetic disease, genetic epidemiology encompasses a variety of aspects of epidemiology, including studies of prevalence, clinical epidemiology, genotype-phenotype relationships, and disease progression and outcomes.
Historical developments
Historically, the field of genetic epidemiology has roots in the areas of medicine concerning the causes and heredity of disease. Prior to the 1950s, before the field was formally established, scientists who perhaps would be labeled as early genetic epidemiologists were trying to unravel the relationship between nature (genetics) and nurture (environment) in human disease. Those activities were in contrast to the activities of early practitioners of medical genetics and genetic counseling. The former tended to be oriented toward clinical and descriptive aspects of diseases with potential genetic involvement, while the latter carried out genetic counseling based on what was known then about the inheritance patterns of some diseases. Early practitioners of genetic epidemiology, on the other hand, often looked for associations between diseases, such as between stomach ulcers and genetic traits of blood groups. In addition, in the early 1960s, when genetic epidemiology was beginning to take form, the legacy of eugenics was still evident in the names of medical journals and organizations.
The early history of attempts to solve the problem of heredity versus environment—that is, nature versus nurture—in causing human disease was subject to shifting emphasis in the importance of one over the other. Both scientific and societal concerns were responsible for driving those swings in perspective over time, whereby the scientific community and society viewed either nature or nurture as the more important determinant in causing diseases. In the modern era, the controversy about nature versus nurture has been gradually replaced by a view that includes roles for both nature and nurture in human disease. Indeed, both genetic and environmental factors have been found to influence disease susceptibility.
Since the latter part of the 20th century, the importance of genetic determinants of human diseases has been increasingly recognized. Meanwhile, human geneticists have described the role of various environmental exposures in human disease. There also has been increasing acceptance of the idea, asserted in 2003 by Khoury, Little, and Burke, that most human disease, if not all, is the result of the interaction between underlying genetic susceptibility and exposures to various components of the environment, including chemical, dietary, infectious, physical, and behavioral factors. The latter would encompass the influences of cultural factors in human behaviour and their interaction with other environmental factors.
Approaches in genetic epidemiology
Various approaches are used in genetic epidemiology, including population-based approaches, case-control studies, and prevalence studies. Population-based approaches, for example, can be used to gather data on clinical features and outcomes in patients with specific diseases and disorders. Knowing the distributional characteristics of socioeconomic and other demographic variables of a study population can provide additional insight into disease.
Other approaches used include linkage studies, which are focused on the tendency of certain genes and other genetic factors to be inherited as a unit (rather then independently). For multifactorial diseases (diseases involving multiple genes), studies involving twins may be used to establish evidence for a role for genetic factors in a disease, while association studies may be used for the detection of susceptibility genes. Family studies of disease risk in first-degree relatives are also used and often include comparisons of familial risk to risk in the population (i.e., prevalence) and, if controls are available (e.g., in case-control studies), to the risk of relatives of control individuals.
An important contribution of epidemiology to the development of genetic epidemiology has been the introduction of traditional epidemiological methods to the mix of study designs. Human quantitative genetics used studies of twins, siblings, half-siblings, and in some cases adoptees to investigate the genetic and environmental sources of variation in human traits and diseases. Application of epidemiological methods such as case-control studies and cohort studies has further extended those methods for examining genetic and environmental risk factors simultaneously. In any of the methods used, the emphasis on a population-based approach becomes important, whether it is the collection of prevalence data in surveillance programs or enhancing the ability to test how representative a specific sample is through an understanding of the characteristics of the larger population.
Contributions to public health
Genetic epidemiology has made important contributions to medicine and public health. One example is the use of newborn screening to detect inherited disorders in offspring. In the United States, a clinical intervention study conducted during the 1980s on sickle cell disease paved the way for expansion of newborn screening programs to include the disease in the programs of more states. The study was a randomized trial to determine the prophylactic (preventative) effects of penicillin administration in children diagnosed with sickle cell disease. A reduction in both the incidence of pneumococcal infections and the mortality in those infants who received penicillin compared with the untreated group led to the conclusion that children should be screened in the newborn period for sickle cell disease and receive penicillin early in the first year of life to prevent the infections. In the late 20th and early 21st centuries, research revealed that familial traits are associated with certain psychiatric disorders and substance dependence in adults and children. That realization has helped genetic epidemiologists to identify specific environmental factors that contribute to the disorders, indicating that preventing exposure to such factors could reduce the risk of developing the disorders.
As human geneticists and epidemiologists search for more optimal strategies to identify disease genes and overcome methodological limitations in dissecting the genetic components of complex diseases, their work continues to aid the translation of the results of genomic research into effective public health measures.
Distinctions from related fields
There are a number of aspects that distinguish genetic epidemiology from other areas of genetics. The first is the population-based nature of genetic epidemiology, which, together with shared methodological approaches, is one of its key links with epidemiology. Second, ways of conceptualizing the field emphasize the search for combined and interactive effects of genetic and environmental factors. Finally, genetic epidemiology includes the consideration of the biological basis of the diseases into developing models of causation for diseases.
In addition, genetic epidemiology is distinct from the field of molecular epidemiology, which grew out of environmental epidemiology. The rationale for the emergence of molecular epidemiology was the need to identify biomarkers of environmental exposures as an application of molecular biology in epidemiology.

" height="20" alt="HEW Logo">